Navarro: Trump may impose 232 tariffs on pharmaceutical products

Wallstreetcn
2025.08.14 15:45
portai
I'm PortAI, I can summarize articles.

White House advisor Navarro stated that U.S. President Trump may impose tariffs on pharmaceutical products under Section 232. This news caused Pfizer's stock price to drop by more than 0.7%, UnitedHealth to decline by more than 0.4%, while Amgen, Johnson & Johnson, and AstraZeneca ADR rose by 0.6%, 0.1%, and 0.4%, respectively. Investment should be approached with caution, and this article does not constitute personal investment advice

White House advisor Navarro claimed that U.S. President Trump's pharmaceutical tariffs may be introduced under Section 232.

As a result, Pfizer is currently down over 0.7%, UnitedHealth is down over 0.4%, Amgen is up 0.6%, Johnson & Johnson is up 0.1%, and AstraZeneca ADR is up 0.4%.

Risk Warning and Disclaimer

The market carries risks, and investments should be made cautiously. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investing based on this is at your own risk

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.